Stem Cell Therapy and Nanotechnology in Diabetes

A successful bone marrow or stem cell transplant may help slow or halt the progression of certain metabolic syndromes including type 1 diabetes, but early diagnosis is critical to prevent irreversible disease progression. Pancreatic islet allotransplantation is a procedure in which islets from the donor pancreas are transferred into another person to treat type 1 diabetes and have been a promising cellular-based therapy. The recent advances in nanomedicine include smart drugs which only activate when needed, nanoformulations for efficient drug delivery, engineered microbes which produce human hormones, and even nanorobots, which would move autonomously around the body acting as a boost, for our immune system, red blood cells, or many other biological systems.

  • Islet Cell Transplantation
  • Embryonic Stem Cells
  • Mesenchymal Stem Cell Therapy

Related Conference of Stem Cell Therapy and Nanotechnology in Diabetes

February 24-25, 2025

34th European Diabetes Congress

London, UK
March 10-11, 2025

4th Global Summit on Physiology and Metabolism of Thyroid

Singapore City, Singapore
March 17-18, 2025

5th European Endocrinology and Diabetes Congress

Paris, France
April 10-11, 2025

5th World Congress on Endocrine and Diabetes

Dubai, UAE
April 10-11, 2025

4th International Summit on Hormonal Disorders

Dubai, UAE
May 19-20, 2025

6th World Summit on Diabetes

Rome, Italy
June 04-05, 2025

4th World Congress on Diabetes and Pediatric Endocrinology

Edinburgh, Scotland
July 29-30, 2025

15th World Congress on Endocrinology and Diabetes

Aix-en-Provence, France
September 08-09, 2025

3rd World congress and Expo on Diabetes

Frankfurt, Germany
November 20-21, 2025

21st World Congress on Endocrinology & Diabetes

Aix-en-Provence, France

Stem Cell Therapy and Nanotechnology in Diabetes Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in